Emcure betting on innovator edge in crowded weight-loss drug market
Semaglutide’s patent expired on Friday, and several top Indian drugmakers will launch cheaper generics immediately, with intense competition expected.
Semaglutide’s patent expired on Friday, and several top Indian drugmakers will launch cheaper generics immediately, with intense competition expected.
What's Your Reaction?
DDP Editor
Admin managing news updates, RSS feed curation, and PR content publishing. Focused on timely, accurate, and impactful information delivery.
